Latest News about ROIV
Recent news which mentions ROIV
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
Roivant' Dermavant Showcases New Long-Term Durability, Tolerability Data For Plaque Psoriasis Candidate
March 25, 2022
Tickers
ROIV
From Benzinga
From Benzinga
Earnings Scheduled For February 14, 2022
February 14, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 22, 2021
From Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
From Benzinga
38 Stocks Moving In Monday's Mid-Day Session
December 20, 2021
From Benzinga
63 Biggest Movers From Friday
December 20, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 14, 2021
From Benzinga
50 Biggest Movers From Friday
December 13, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 02, 2021
From Benzinga
61 Biggest Movers From Yesterday
December 02, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 01, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 01, 2021
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
From Benzinga
Earnings Scheduled For November 15, 2021
November 15, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021
November 08, 2021
From Benzinga
60 Biggest Movers From Yesterday
October 27, 2021
From Benzinga
Why Roivant Sciences Stock Is Soaring Today
October 26, 2021
From Motley Fool
40 Stocks Moving In Tuesday's Mid-Day Session
October 26, 2021
From Benzinga
From InvestorPlace
23 Stocks Moving in Thursday's Pre-Market Session
October 21, 2021
From Benzinga
GME Stock: What GameStop Investors Are Saying About the Mega Meme Stock as Shares Surge Today
October 11, 2021
From InvestorPlace
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
36 Biggest Movers From Yesterday
October 06, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
